20 March 2020 - Deborah Wilkes
Archived
Two applications to switch medicines from prescription to non-prescription status through the European Union’s centralised authorisation procedure are set to be discussed by the Committee for Medicinal Products for Human Use (CHMP).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.